Viral load-guided immunosuppression after lung transplantation (VIGILung)—study protocol for a randomized controlled trial

Viral load-guided immunosuppression after lung transplantation (VIGILung)—study protocol for a randomized controlled trial

Abstract Background Immunosuppression including high-dose calcineurin inhibitors (CNI) is essential after lung transplantation. Dosing is usually guided by therapeutic drug monitoring adjusted to target trough levels of CNIs to keep the balance between over-dose causing severe toxicity and increased...

Full description

Bibliographic Details
Main Authors: Jens Gottlieb, Alexander Reuss, Konstantin Mayer, Karin Weide, Carmen Schade-Brittinger, Susanne Hoyer, Peter Jaksch
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Trials
Subjects:
Lung transplantation
Immunosuppression
Graft rejection
Kidney failure
Torque teno virus
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13063-020-04985-w

Internet

https://doi.org/10.1186/s13063-020-04985-w

Similar Items